Sun Pharma buys Japanese company for $1m
26-11-2018
Marques / Shutterstock.com
India-based pharmaceutical company Sun Pharmaceutical has acquired 14 prescription brands from Novartis in Japan for $293 million.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Sun Pharmaceutical, Novartis, Dilip Shanghvi, patent, portfolio, prescription brands, marketing
